Mraz Amerine & Associates’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
Other funds holding RPRX
Mraz Amerine & Associates's RPRX Position: Q3 2026 in Review
Mraz Amerine & Associates held its Royalty Pharma (RPRX) position steady in Q3 2026 at 4,550 shares worth $266K. The position accounts for 0.04% of the portfolio, ranked #146.
Mraz Amerine & Associates first reported a position in RPRX in Q1 2026 and has held it in 3 quarters since. 707 funds tracked by Wall St. Rank hold RPRX as of Q3 2026.
- Mraz Amerine & Associates held 4,550 shares of Royalty Pharma worth $266K as of Q3 2026.
- Mraz Amerine & Associates left its Royalty Pharma share count unchanged in Q3 2026.
- Royalty Pharma made up 0.04% of Mraz Amerine & Associates's portfolio in Q3 2026, its #146 holding.
- Mraz Amerine & Associates first reported a position in Royalty Pharma in Q1 2026 and has held it in 3 quarters since.
- 707 funds tracked by Wall St. Rank held Royalty Pharma as of Q3 2026.
Based on Mraz Amerine & Associates's 13F filing for Q3 2026, filed 30 Oct 2026.